|
[1]
|
Nandhini, P., Kumar, P., Mickymaray, S., Alothaim, A.S., Somasundaram, J. and Rajan, M. (2022) Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review. Antibiotics, 11, Article 606. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Nielsen, K.T., Petersen, B.I., Xu, L., et al. (2024) The SPX Stress Regulator Confers High-Level β-Lactam Resistance and Decreases Susceptibility to Last-Line Antibiotics in Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 68, e0033524.
|
|
[3]
|
Alabdullatif, M. and Alzahrani, A. (2022) Expression of Biofilm-Associated Genes in Staphylococcus aureus during Storage of Platelet Concentrates. Transfusion and Apheresis Science, 61, Article 103456. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Różalski, M.I., Micota, B., Sadowska, B., Paszkiewicz, M., Więckowska-Szakiel, M. and Różalska, B. (2013) Antimicrobial/Anti-Biofilm Activity of Expired Blood Platelets and Their Released Products. Postepy Higieny i Medycyny Doswiadczalnej (Online), 67, 321-325.
|
|
[5]
|
Gilbertie, J.M., Schaer, T.P., Engiles, J.B., Seiler, G.S., Deddens, B.L., Schubert, A.G., et al. (2022) A Platelet-Rich Plasma-Derived Biologic Clears Staphylococcus aureus Biofilms While Mitigating Cartilage Degeneration and Joint Inflammation in a Clinically Relevant Large Animal Infectious Arthritis Model. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 895022.
|
|
[6]
|
Schuetz, A.N., Ferrell, A., Hindler, J.A., Humphries, R. and Bobenchik, A.M. (2025) Overview of Changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd Editions. Journal of Clinical Microbiology, 63, e0162323. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
刘二雄, 王文婷, 徐金梅, 等. 血小板对5种常见致病菌抗菌效果的比较分析[J]. 中国输血杂志, 2025, 38(6): 747-758.
|
|
[8]
|
Bećirević, T., Eminović, I., Mehmedinović, N.I., Omeragić, E., Falan, E., Papračanin, E., et al. (2024) Evaluation of Platelet-Enriched Plasma Antimicrobial Effect: In Vitro Study. In: Badnjević, A. and Gurbeta Pokvić, L. Eds., IFMBE Proceedings, Springer, 22-28. [Google Scholar] [CrossRef]
|
|
[9]
|
Koo, S., Bayer, A.S., Kagan, B.L. and Yeaman, M.R. (1999) Membrane Permeabilization by Thrombin-Induced Platelet Microbicidal Protein 1 Is Modulated by Transmembrane Voltage Polarity and Magnitude. Infection and Immunity, 67, 2475-2481. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ngo, A.T.P., Bochenek, V., Kim, H., Levine, N., Maarouf, S., Oberg, J., et al. (2024) Platelet Factor 4 Enhances Endothelial Cell Antimicrobial Activity in Vitro and Promotes Bacterial Clearance in Vivo, Improving Sepsis Outcomes. Blood, 144, 1231-1231. [Google Scholar] [CrossRef]
|
|
[11]
|
Ceresa, C., Travagin, F., Marchetti, A., Tessarolo, F., Fracchia, L., Giovenzana, G.B., et al. (2024) An in Vitro Study on the Application of Silver-Doped Platelet-Rich Plasma in the Prevention of Post-Implant-Associated Infections. International Journal of Molecular Sciences, 25, Article 4842. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Sun, L., Yu, Y., Peng, Y., Wang, D., Wang, S., Noh, I., et al. (2023) Platelet Membrane‐Derived Nanodiscs for Neutralization of Endogenous Autoantibodies and Exogenous Virulence Factors. Small, 20, e2308327. [Google Scholar] [CrossRef] [PubMed]
|